X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.03
Delayed Data
As of May 21
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.00
+2.53%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +195.57% increase from the last price of 2.03.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in X T L Biopharmaceuticals Ltd. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
--
Reporting Date
Sep 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 50.00%
 
 
 
 
 
 
Growthannually 45.45%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually 554.90%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account